Pramipexole ER 0,375 Teva


Extended release tablet
scheduling status
S4
registration number
50/5.4.1/0800
What Pramipexole ER 0,375 Teva contains
Pramipexole dihydrochloride monohydrate 0,375 mg which is equivalent to pramipexole 0,26 mg.
other ingredients
Colloidal silicon dioxide, dibasic calcium phosphate anhydrous, hypromellose 2208 fibrous powder, hypromellose 2208 granular powder and magnesium stearate.
Therapeutic classification
N04B C05 - dopamine agonists (specifically stimulating dopamine receptors).
© 2026 SAHPRA. ALL RIGHTS RESERVED